Загрузка...
Initial Testing (Stage 1) of the Notch Inhibitor PF-03084014, by the Pediatric Preclinical Testing Program
PF-03084014, a γ-secretase inhibitor, was tested against the PPTP in vitro cell line panel (1.0 nM to 10 μM) and against the in vivo xenograft panels (administered orally twice daily on days 1–7 and 15–21). PF-03084014 demonstrated limited in vitro activity, with no cell line achieving ≥50% inhibiti...
Сохранить в:
| Опубликовано в: : | Pediatr Blood Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225044/ https://ncbi.nlm.nih.gov/pubmed/24664981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25026 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|